Physician profile
Poonam Warman
NPI 1871508549
$1,659.95
in general payments reported to CMS, 2019-2025
19 companies · $27.99 in 2025
The $27.99 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.30 · 2020: $205 · 2021: $514 · 2022: $152 · 2023: $61.80 · 2024: $647 · 2025: $27.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $376 · Travel and Lodging: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $375.92 |
| Travel and Lodging | $360.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noah Medical Corporation | $360.85 | 2024 | Galaxy |
| Regeneron Healthcare Solutions, INC. | $195.15 | 2021-2024 | Dupixent |
| Grifols USA, LLC | $148.03 | 2019-2023 | Prolastin-C Liquid |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2020 | |
| United Therapeutics Corporation | $124.99 | 2024 | Tyvaso |
| Acelrx Pharmaceuticals, INC. | $120.02 | 2021 | |
| Baxter Healthcare | $114.17 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Electromed, INC. | $83.88 | 2021-2024 | Smartvest |
| Glaxosmithkline, LLC. | $79.27 | 2019-2025 | Nucala |
| Gilead Sciences, INC. | $59.12 | 2021-2024 | |
| Amgen INC. | $56.98 | 2020-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $54.47 | 2021-2024 | Farxiga |
| Novartis Pharmaceuticals Corporation | $29.87 | 2024 | |
| Mylan Specialty L.P. | $20.18 | 2019 | |
| Inogen, INC. | $19.15 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $18.60 | 2024 | Mounjaro |
| Advanced Respiratory, INC | $18.44 | 2021 | |
| Radius Health, INC. | $15.94 | 2020 | |
| Genzyme Corporation | $15.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Poonam Warman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.